Cargando…

HAPIscreen, a method for high-throughput aptamer identification

BACKGROUND: Aptamers are oligonucleotides displaying specific binding properties for a predetermined target. They are selected from libraries of randomly synthesized candidates through an in vitro selection process termed SELEX (Systematic Evolution of Ligands by EXponential enrichment) alternating...

Descripción completa

Detalles Bibliográficos
Autores principales: Dausse, Eric, Taouji, Saïd, Evadé, Laetitia, Di Primo, Carmelo, Chevet, Eric, Toulmé, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127992/
https://www.ncbi.nlm.nih.gov/pubmed/21639912
http://dx.doi.org/10.1186/1477-3155-9-25
_version_ 1782207398932381696
author Dausse, Eric
Taouji, Saïd
Evadé, Laetitia
Di Primo, Carmelo
Chevet, Eric
Toulmé, Jean-Jacques
author_facet Dausse, Eric
Taouji, Saïd
Evadé, Laetitia
Di Primo, Carmelo
Chevet, Eric
Toulmé, Jean-Jacques
author_sort Dausse, Eric
collection PubMed
description BACKGROUND: Aptamers are oligonucleotides displaying specific binding properties for a predetermined target. They are selected from libraries of randomly synthesized candidates through an in vitro selection process termed SELEX (Systematic Evolution of Ligands by EXponential enrichment) alternating selection and amplification steps. SELEX is followed by cloning and sequencing of the enriched pool of oligonucleotides to enable comparison of the selected sequences. The most represented candidates are then synthesized and their binding properties are individually evaluated thus leading to the identification of aptamers. These post-selection steps are time consuming and introduce a bias to the expense of poorly amplified binders that might be of high affinity and are consequently underrepresented. A method that would circumvent these limitations would be highly valuable. RESULTS: We describe a novel homogeneous solution-based method for screening large populations of oligonucleotide candidates generated from SELEX. This approach, based on the AlphaScreen(® )technology, is carried out on the exclusive basis of the binding properties of the selected candidates without the needs of performing a priori sequencing. It therefore enables the functional identification of high affinity aptamers. We validated the HAPIscreen (High throughput APtamer Identification screen) methodology using aptamers targeted to RNA hairpins, previously identified in our laboratory. We then screened pools of candidates issued from SELEX rounds in a 384 well microplate format and identify new RNA aptamers to pre-microRNAs. CONCLUSIONS: HAPIscreen, an Alphascreen(®)-based methodology for the identification of aptamers is faster and less biased than current procedures based on sequence comparison of selected oligonucleotides and sampling binding properties of few individuals. Moreover this methodology allows for screening larger number of candidates. Used here for selecting anti-premiR aptamers, HAPIscreen can be adapted to any type of tagged target and is fully amenable to automation.
format Online
Article
Text
id pubmed-3127992
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31279922011-07-01 HAPIscreen, a method for high-throughput aptamer identification Dausse, Eric Taouji, Saïd Evadé, Laetitia Di Primo, Carmelo Chevet, Eric Toulmé, Jean-Jacques J Nanobiotechnology Research BACKGROUND: Aptamers are oligonucleotides displaying specific binding properties for a predetermined target. They are selected from libraries of randomly synthesized candidates through an in vitro selection process termed SELEX (Systematic Evolution of Ligands by EXponential enrichment) alternating selection and amplification steps. SELEX is followed by cloning and sequencing of the enriched pool of oligonucleotides to enable comparison of the selected sequences. The most represented candidates are then synthesized and their binding properties are individually evaluated thus leading to the identification of aptamers. These post-selection steps are time consuming and introduce a bias to the expense of poorly amplified binders that might be of high affinity and are consequently underrepresented. A method that would circumvent these limitations would be highly valuable. RESULTS: We describe a novel homogeneous solution-based method for screening large populations of oligonucleotide candidates generated from SELEX. This approach, based on the AlphaScreen(® )technology, is carried out on the exclusive basis of the binding properties of the selected candidates without the needs of performing a priori sequencing. It therefore enables the functional identification of high affinity aptamers. We validated the HAPIscreen (High throughput APtamer Identification screen) methodology using aptamers targeted to RNA hairpins, previously identified in our laboratory. We then screened pools of candidates issued from SELEX rounds in a 384 well microplate format and identify new RNA aptamers to pre-microRNAs. CONCLUSIONS: HAPIscreen, an Alphascreen(®)-based methodology for the identification of aptamers is faster and less biased than current procedures based on sequence comparison of selected oligonucleotides and sampling binding properties of few individuals. Moreover this methodology allows for screening larger number of candidates. Used here for selecting anti-premiR aptamers, HAPIscreen can be adapted to any type of tagged target and is fully amenable to automation. BioMed Central 2011-06-03 /pmc/articles/PMC3127992/ /pubmed/21639912 http://dx.doi.org/10.1186/1477-3155-9-25 Text en Copyright ©2011 Dausse et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dausse, Eric
Taouji, Saïd
Evadé, Laetitia
Di Primo, Carmelo
Chevet, Eric
Toulmé, Jean-Jacques
HAPIscreen, a method for high-throughput aptamer identification
title HAPIscreen, a method for high-throughput aptamer identification
title_full HAPIscreen, a method for high-throughput aptamer identification
title_fullStr HAPIscreen, a method for high-throughput aptamer identification
title_full_unstemmed HAPIscreen, a method for high-throughput aptamer identification
title_short HAPIscreen, a method for high-throughput aptamer identification
title_sort hapiscreen, a method for high-throughput aptamer identification
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127992/
https://www.ncbi.nlm.nih.gov/pubmed/21639912
http://dx.doi.org/10.1186/1477-3155-9-25
work_keys_str_mv AT dausseeric hapiscreenamethodforhighthroughputaptameridentification
AT taoujisaid hapiscreenamethodforhighthroughputaptameridentification
AT evadelaetitia hapiscreenamethodforhighthroughputaptameridentification
AT diprimocarmelo hapiscreenamethodforhighthroughputaptameridentification
AT cheveteric hapiscreenamethodforhighthroughputaptameridentification
AT toulmejeanjacques hapiscreenamethodforhighthroughputaptameridentification